Fraxinus excelsior Seed Extract for Diabetes Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Type 2 diabetes mellitus (DM-2) and obesity-related diseases pose significant health challenges due to insulin deficiency, insulin insensitivity, and increasing prevalence of obesity, with current treatments having limitations in effectively managing blood glucose and weight.
Innovation Solution
Isolation and extraction of novel secoiridoids from Fraxinus excelsior seeds, specifically excelside A and B, which are oleoside-type secoiridoids, using a unique extraction and chromatographic process, and their use in activating PPAR-alpha to inhibit adipogenesis and improve insulin sensitivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional extraction methods are used to obtain bioactive compounds from plant material, then the extraction process is simple and quick, but the extraction efficiency and yield of active compounds are low
Solution Approach 1:
The extraction process is divided into multiple sequential steps: initial extraction with organic solvent, filtration, concentration, and sequential elution with solvents of increasing polarity (water, ethanol, methanol, acetone). This segmentation allows each step to optimize for specific compound classes, dramatically improving overall extraction efficiency and yield of bioactive compounds compared to single-step methods.
Solution Approach 2:
The patent performs preliminary actions by first extracting with non-polar solvents to remove lipids and chlorophylls, then progressively using polar solvents to extract phenolic compounds, flavonoids, and other polar bioactives. This preliminary separation prevents interference between compound classes and maximizes the yield of target compounds in each fraction.
2Adaptability or versatility
If a broad spectrum of therapeutic agents is used to treat type 2 diabetes, then more treatment options are available, but the complexity of treatment regimens increases
Solution Approach 1:
The Fraxinus excelsior seed extract demonstrates multi-functionality by simultaneously exhibiting hypoglycemic activity (blood glucose lowering), antioxidant properties, anti-inflammatory effects, and potential lipid-lowering capabilities. This single extract can address multiple pathogenic mechanisms of type 2 diabetes concurrently, providing versatile treatment without requiring multiple separate medications or complex regimens.
Solution Approach 2:
The patent utilizes a composite phytochemical mixture from F. excelsior seeds containing diverse compounds including phenolic acids, flavonoids, secoiridoids, and triterpenoids. This composite formulation leverages synergistic interactions between different compound classes to achieve enhanced therapeutic effects for diabetes management, combining multiple mechanisms of action in a single treatment.
3Ease of operation
If traditional medicines are used to treat type 2 diabetes, then cultural relevance and accessibility are improved, but the standardization and quality control become difficult
Solution Approach 1:
The patent establishes specific quantitative parameters for the extract including concentration ranges of key bioactive compounds (phenolic acids, flavonoids, secoiridoids), extraction conditions (solvent ratios, temperatures, durations), and yield specifications. By defining these critical parameters, the traditional remedy can be standardized for consistent quality, potency, and safety while maintaining accessibility through natural product formulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The secoiridoids from Fraxinus excelsior seeds demonstrate significant hypoglycemic activity, reduce body weight, and improve insulin sensitivity by inhibiting adipogenesis and activating PPAR-alpha, effectively managing DM-2 and obesity-related conditions.
Implementation Method 1
The seeds are ground into granules with a particle size in a range from 0.1 mm to 30 mm to increase the surface area for the solvent to contact and to increase extraction efficiency
Implementation Method 2
The secoiridoids can be isolated from the FE extract by a chromatographic process
Data Source
Figure 1-1~1-2
Figure 1-3~1-4
Figure 1-5~1-6
AI summary
A Fraxinus excelsior seed extract that can be administered for therapeutic treatment of a subject, including a human, by blocking fat synthesis, activating PPAR-alpha, increasing hypoglycemic activity, reducing bodyweight, controlling fasting plasma insulin levels against hyperinsulinemia, and promoting insulin sensitivity and causing a beneficial acute insulinotropic effect. The Fraxinus excelsior seed extract includes, inter alia, an isolated compound (2S, 3E, 4S) 2H-Pyran-4-acetic acid-3-ethylidene-2-[(6-O-β-D-glucopyranosyl-β-D-glucopyranosyl) oxy]-3,4-dihydro-5-(methoxycarbonyl) methyl ester, commonly called excelside A, an isolated compound (2S, 3E, 4S) 2H-Pyran-4-acetic acid-3-ethylidene-2-[(6-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-3,4-dihydro-5-(methoxycarbonyl)2-(4- hydroxyphenyl) ethyl ester, commonly called excelside B, and the compounds GI5, GI3, nuzhenide, and oleoside dimethyl ester.